Non Invasive Ventilation, Preoxygenation
Conditions
Brief summary
During preoxygenation, imperfect seal between the face mask and patient's face can induce an inward air leak decreasing its effectiveness. We assume that noninvasive ventilation could cancel the effect of the leak. This is a prospective study. Healthy volunteers are randomised in cross-over between spontaneous breathing or noninvasive ventilation pressure support preoxygenation in the presence or absence of a calibrated leak on the inspiratory circuit.
Detailed description
During preoxygenation, imperfect seal between the face mask and patient's face can induce an inward air leak decreasing its effectiveness. We assume that noninvasive ventilation could cancel the effect of the leak. We planned an experimental study with healthy volunteers (residents in anesthesiology). Healthy volunteers are randomised in cross-over between preoxygenation through spontaeous breathing or noninvasive ventilation pressure support preoxygenation in the presence or absence of a calibrated leak on the inspiratory circuit. The inspiratory fraction of oxygen is 100%. The exhaled gas (oxygen and carbon dioxide) are monitored.The subjects breathed through a mouthpiece (with a nose clip) connected to an anesthetic ventilator. The primary endpoint is the time to achieve end expiratory fraction of oxygene of 90% or more. The secondary endpoint is the proportion of subject with end expiratory fraction of oxygen of 90% or more after a 3 min period (recommended in clinical guidelines).
Interventions
breathing a 100% inspired oxygen gas flow during 3 to 10 minutes
breathing a 100% inspired oxygen gas flow during 3 to 10 minutes with an inward air leak made possible through a specific calibrated piece on the inspiratory branch
Sponsors
Study design
Intervention model description
2 groups : spontaneous breathing and non invasive pressure support ventilation 2 conditions : without inward air leak and with inward air leak
Eligibility
Inclusion criteria
* healthy volunteers
Exclusion criteria
* any pathological condition * active tobaco
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| end expiratory fraction of oxygen | 10 minutes | end expiratory fraction of oxygen measured in exhaled gas |
Countries
France